Search for: "US v. Isom"
Results 41 - 60
of 93
Sorted by Relevance
|
Sort by Date
16 May 2023, 1:41 pm
Schedule I has the most severe sentencing range, with Schedule V the least. [read post]
10 Feb 2014, 2:01 am
Perhaps the most important exclusion from patentability, discussed further below, is India’s Section 3(d).The authors cited Pfizer v. [read post]
16 Apr 2018, 2:48 pm
Bard, Inc. v. [read post]
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem)… [read post]
9 Oct 2019, 12:38 pm
If the facts of Isom v. [read post]
5 Jul 2017, 5:22 pm
State v. [read post]
25 Nov 2019, 10:33 am
The issue arose in Gundy v. [read post]
26 Apr 2011, 11:40 am
In Merck Eprova AG v. [read post]
1 Feb 2016, 8:11 am
By Dennis Crouch Purdue Pharma v. [read post]
19 Jan 2019, 3:47 pm
In Re Isom v. [read post]
30 Aug 2016, 7:52 am
This judgment [Hospira UK Ltd v Cubist Pharmaceuticals LLC [2016] EWHC 1285 (Pat) (10 June 2016)] was handed down a little while ago, but this Kat only recently got round to studying it properly, containing as it does decisions relating to three rather different patents. [read post]
30 Oct 2023, 5:28 am
In the North Carolina case of Isom v. [read post]
5 Apr 2011, 6:19 am
Merck Eprova AG v. [read post]
23 Feb 2022, 7:43 am
See State v. [read post]
22 Jul 2010, 1:11 pm
Sciele Pharma, Inc. v. [read post]
14 Sep 2021, 5:27 am
State v. [read post]
11 Jan 2023, 9:18 am
Consumable v. [read post]
8 Nov 2007, 12:10 pm
State of Indiana (NFP) Billy Ray Isom v. [read post]
1 Jul 2007, 11:53 pm
., et al. v. [read post]
13 May 2009, 11:44 pm
Ltd. v. [read post]
